Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Anil Bharani Department of Medicine, MGM
Medical College and MY Hospital, Indore 452001, India Nephrogenic diabetes insipidus occurs with agents
such as lithium, methoxyfluorane, vitamin D, and
demeclocycline.
1 2
We report a case of diabetes insipidus
induced by ofloxacin (Tarivid; Hoescht Marion Roussel).
A 25 year old man was admitted with fever, a dry cough, and
dyspnoea of three days' duration. He had had an influenza-like illness in the preceding week, and his doctor had prescribed ampicillin 2 g daily for three days. On examination he was febrile, toxic, dyspnoeic, and had poor oral hygiene. His pulse was 130 beats/min, blood pressure 110/70 mm Hg, and respiration 35 breaths/min. A chest
examination showed signs of bilateral lobar consolidation of the mid
zones. His total white blood cell count was 20×109/l with
90% polymorphs, the results of blood biochemistry were normal, and he
had negative results for hepatitis B surface antigen, HIV-1, and HIV-2.
A chest x ray film showed bilateral lobar infiltrates, no pleural reaction, and a normal cardiac silhouette. We diagnosed "typical" bilateral lobar pneumonia acquired in the community after
influenza. He was treated with multiple antibiotics as sputum and
relevant bacteriology results could not be obtained: penicillin G 2 million units four times daily, gentamicin 60 mg every eight hours,
clarithromycin 500 mg twice daily, and metronidazole 400 mg every eight
hours. He was also given a mucolytic, intravenous fluids, vitamins, and
intranasal oxygen.
On the third day after admission his response was poor and he was given
ofloxacin 200 mg twice daily. He seemed to improve, but on the fifth
day he developed polyuria (>20 l/day) with excessive thirst (urine
264 mOsmol/kg with urinary sodium excretion 286 mmol/day).
Ofloxacin induced diabetes insipidus was suspected, and the drug was
stopped. His urine volume gradually decreased and his thirst normalised
within 36 hours while the other drugs were continued. As he continued
to improve we rechallenged him with ofloxacin 400 mg daily. Again his
urine production increased in association with polydipsia. Ofloxacin
was stopped. A chest x ray film showed resolution of the
pneumonic consolidation. Multiple cavity formation bilaterally
suggested infection with Staphylococcus aureus. He was given
ceftriazone 2 g daily and cloxacillin 500 mg four times daily. His
symptoms resolved after two weeks.
That the diabetes insipidus recurred when he was rechallenged
with ofloxacin and resolved after the drug was stopped while other
treatment was continued suggests a causal relation. We could find no
report on ofloxacin induced diabetes insipidus in the published
literature or from the product monograph. We reported this side
effect to the manufacturer and the Central Drug Standard Control
Organisation (west zone), both of which were unaware of any such
report. Similarly, the other drugs the patient took were unlikely
to interact to cause a diabetes insipidus-like syndrome. The mechanism
of this interaction is not clear; it could be similar to that of
lithium or demeclocycline, which interferes with the action of
antidiuretic hormone on the collecting ducts.
1 2
Footnotes
Competing interests: None declared.
References
| 1. | Moses AM, Streeten DHP. Disorders of the neurohypophysis. In: Isselbacher KJ, Braunwald E, Wilson JD, eds. Harrison's principles of internal medicine 13th ed. NewYork: McGraw-Hill, 1994:1921-1930. |
| 2. | Forrest Jr JN, Cox IM, Hong C, Morrison G, Bia M, Singer I. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1978; 298: 173-177[Abstract]. |
Read all Rapid Responses